Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 188

    1.

    Sympathomimetic agents in the treatment of shock.

    Tarazi RC.

    Ann Intern Med. 1974 Sep;81(3):364-71. Review.PMID: 4605195 [PubMed - indexed for MEDLINE]Related articles

    2.

    Treatment of circulatory shock. Use of sympathomimetic and related vasoactive agents.

    Weil MH, Shubin H, Carlson R.

    JAMA. 1975 Mar 24;231(12):1280-6.PMID: 235029 [PubMed - indexed for MEDLINE]Related articles

    3.

    [New inotropic agents in the treatment of congestive heart failure]

    Freitas M.

    Rev Port Cardiol. 1993 Nov;12 Suppl 4:19-28, 7-8. Review. Portuguese. PMID: 7904458 [PubMed - indexed for MEDLINE]Related articles

    4.

    Vasopressor agents in shock.

    Moyer JH, Mills LC.

    Am J Nurs. 1975 Apr;75(4):620-5.PMID: 1039254 [PubMed - indexed for MEDLINE]Related articles

    5.

    Effects of norepinephrine plus dobutamine or norepinephrine alone on left ventricular performance of septic shock patients.

    Martin C, Viviand X, Arnaud S, Vialet R, Rougnon T.

    Crit Care Med. 1999 Sep;27(9):1708-13.PMID: 10507587 [PubMed - indexed for MEDLINE]Related articles

    6.

    Regulation of coronary blood flow during exercise.

    Duncker DJ, Bache RJ.

    Physiol Rev. 2008 Jul;88(3):1009-86. Review.PMID: 18626066 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Effect of vasopressors on organ blood flow during endotoxin shock in pigs.

    Breslow MJ, Miller CF, Parker SD, Walman AT, Traystman RJ.

    Am J Physiol. 1987 Feb;252(2 Pt 2):H291-300.PMID: 3544876 [PubMed - indexed for MEDLINE]Related articles

    8.

    Hemodynamics, coronary blood flow, and myocardial metabolism in coronary shock; response of 1-norepinephrine and isoproterenol.

    Mueller H, Ayres SM, Gregory JJ, Giannelli S Jr, Grace WJ.

    J Clin Invest. 1970 Oct;49(10):1885-902.PMID: 5460498 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Vasopressors for treating shock.

    Moyer JH, Mills LC.

    Postgrad Med. 1974 Aug;56(2):172-80.PMID: 4855378 [PubMed - indexed for MEDLINE]Related articles

    10.

    Low-dose vasopressin in the treatment of vasodilatory septic shock.

    Malay MB, Ashton RC Jr, Landry DW, Townsend RN.

    J Trauma. 1999 Oct;47(4):699-703; discussion 703-5.PMID: 10528604 [PubMed - indexed for MEDLINE]Related articles

    11.

    Effects of short-term simultaneous infusion of dobutamine and terlipressin in patients with septic shock: the DOBUPRESS study.

    Morelli A, Ertmer C, Lange M, Dünser M, Rehberg S, Van Aken H, Pietropaoli P, Westphal M.

    Br J Anaesth. 2008 Apr;100(4):494-503. Epub 2008 Feb 27.PMID: 18308741 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    The dilemma of vasopressors and vasodilators in the therapy of shock.

    Shoemaker WC, Brown RS.

    Surg Gynecol Obstet. 1971 Jan;132(1):51-7. No abstract available. PMID: 5538813 [PubMed - indexed for MEDLINE]Related articles

    13.

    [Does chronic oral treatment with beta-receptor blockers have an effect on positive inotropic therapy of coronary patients with adrenaline after extracorporeal circulation?]

    Günnicker M, Brinkmann M, Freund U, Piotrowski J, Schieffer M, Velser U.

    Herz. 1995 Dec;20(6):399-411. German. PMID: 8582699 [PubMed - indexed for MEDLINE]Related articles

    14.

    Effects of dobutamine on left ventricular performance, coronary dynamics, and distribution of cardiac output in conscious dogs.

    Vatner SF, McRitchie RJ, Braunwald E.

    J Clin Invest. 1974 May;53(5):1265-73.PMID: 4825224 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Systemic, pulmonary and coronary haemodynamic actions of the novel dopamine receptor agonist in awake pigs at rest and during treadmill exercise Z1046.

    Duncker DJ, Haitsma DB, van der Geest IE, Stubenitsky R, van Meegen JR, Man in't Veld AJ, Verdouw PD.

    Br J Pharmacol. 1997 Mar;120(6):1101-13.PMID: 9134223 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    A novel alpha 2-adrenoceptor antagonist attenuates the early, but preserves the late cardiovascular effects of intravenous dexmedetomidine in conscious dogs.

    Pagel PS, Proctor LT, Devcic A, Hettrick DA, Kersten JR, Tessmer JP, Farber NE, Schmeling WT, Warltier DC.

    J Cardiothorac Vasc Anesth. 1998 Aug;12(4):429-34.PMID: 9713732 [PubMed - indexed for MEDLINE]Related articles

    17.

    Pharmacologic aspects of intrinsic sympathomimetic activity in beta-blocking drugs.

    Prichard BN.

    Am J Cardiol. 1987 May 15;59(13):13F-17F. Review.PMID: 2883871 [PubMed - indexed for MEDLINE]Related articles

    18.

    Terlipressin or norepinephrine in hyperdynamic septic shock: a prospective, randomized study.

    Albanèse J, Leone M, Delmas A, Martin C.

    Crit Care Med. 2005 Sep;33(9):1897-902.PMID: 16148457 [PubMed - indexed for MEDLINE]Related articles

    19.

    Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).

    Watson D, Grover R, Anzueto A, Lorente J, Smithies M, Bellomo R, Guntupalli K, Grossman S, Donaldson J, Le Gall JR; Glaxo Wellcome International Septic Shock Study Group.

    Crit Care Med. 2004 Jan;32(1):13-20.PMID: 14707555 [PubMed - indexed for MEDLINE]Related articles

    20.

    Effects of perfusion pressure on tissue perfusion in septic shock.

    LeDoux D, Astiz ME, Carpati CM, Rackow EC.

    Crit Care Med. 2000 Aug;28(8):2729-32.PMID: 10966242 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data